3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
2
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2678
Pancreatic Neoplasms
1470
Colonic Neoplasms
1159
Carcinoma, Hepatocellular
1142
Stomach Neoplasms
1127
Rectal Neoplasms
980
Esophageal Neoplasms
728
Neoplasms
559
Liver Neoplasms
533
Breast Neoplasms
473
Neoplasm Metastasis
373
Lung Neoplasms
325
Carcinoma, Non-Small-Cell Lung
292
Gastrointestinal Neoplasms
277
Ovarian Neoplasms
258
Prostatic Neoplasms
229
Cholangiocarcinoma
221
Head and Neck Neoplasms
180
Gastrointestinal Stromal Tumors
176
Melanoma
165
Esophageal Squamous Cell Carcinoma
164
Barrett Esophagus
156
Uterine Cervical Neoplasms
151
Biliary Tract Neoplasms
149
Adenocarcinoma Of Esophagus
148
Gallbladder Neoplasms
136
Carcinoma, Renal Cell
134
Urinary Bladder Neoplasms
132
Sarcoma
131
Anus Neoplasms
124
Interventions
beta Carotene
1
Vitamin E
1
Geritol
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Eye Diseases
×
Gastrointestinal
×
Clear all
NCT00270647
2018-02-28
PHS II
Brigham and Women's Hospital
Phase NA
Completed
14,641 enrolled